ATXI Stock Chart

Avenue Therapeutics, a Fortress Biotech Company, is a specialty pharmaceutical company that acquires/in-licenses, develops and commercializes products principally for use in the acute/hospital setting. The Company's initial product candidate is an intravenous formulation of tramadol HCI for the treatment of moderate to moderately severe post-operative pain. Avenue Therapeutics plans to seek additional products to develop in the acute/hospital setting in addition to IV Tramadol.